Acute Porphyria Drug Database

R01AA05 - Oxymetazoline
Propably not porphyrinogenic
PNP

Rationale
Low dose, probably only insignificant systemic exposure.
Chemical description
(To be edited, initial data ST OCT 04) Sympaticomimetic effective in high dilution (nasal drops/spray 0,25 mg/mL). Long duration of effect, needs only to be administered 2-3 times/24 h. No data on the extent of systemic absorbtion or metabolism.
IPNet drug reports
Uneventful use reported in 12 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AA or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙